| 77.11 Delayed Data As of 4:00pm ET |  -0.31 / -0.40%Today’s Change | 52.83 Today|||52-Week Range 80.19 | +37.04% Year-to-Date |
| Previous close | 77.42 |
| Today’s open | 77.92 |
| Day’s range | 76.54 - 78.31 |
| Volume | 13,232,513 |
| Average volume (3 months) | 10,469,113 |
| Market cap | $194.5B |
| Earnings growth (last year) | -38.03% |
| Earnings growth (this year) | +9.06% |
| Earnings growth (next 5 years) | +8.77% |
| Revenue growth (last year) | +1.23% |
| P/E ratio | 62.6 |
| Price/Sales | 3.87 |
| Price/Book | 5.87 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.32 | +0.37% |
| PFEPfizer | -0.39 | -0.88% |
| ABBVAbbVie | +0.56 | +0.64% |
| ABTAbbott Laboratories | +0.92 | +1.30% |
| Next reporting date | February 1, 2019 |
| EPS forecast (this quarter) | $1.05 |
| Annual revenue (last year) | $40.0B |
| Annual profit (last year) | $2.4B |
| Net profit margin | 5.99% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer Kenneth C. Frazier |
CFO & Executive Vice President-Global Services Robert M. Davis |
Corporate headquarters Kenilworth, New Jersey |
